REGN Exercise Disclosure
Guarini Kathryn · SEC Form 4 · Filed Nov 3, 2026
Exercise
Calculated transaction value
$287.75K
Guarini Kathryn Director
REGN
Transaction date
Oct 30, 2026
Public filing date
Nov 3, 2026
Filing lag
Filed 4 days later
REGN daily price context
Close on/before transaction
$927.89
Oct 30, 2026
First close after public filing
$930.67
Nov 4, 2026
Return after filing · so far
-2.83%
Through Nov 6, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 400 shares @ $719.37
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001992352-26-000009
Filing cohort
Transactions in this filing
Showing 3 of 3
Trades
3
Issuers
1
Estimated value
$647.75K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Regeneron Pharmaceuticals, Inc. REGN Current | Exercise | Oct 30, 2026 | $287.75K |
| Regeneron Pharmaceuticals, Inc. REGN | Sale | Oct 30, 2026 | $360K |
| Regeneron Pharmaceuticals, Inc. REGN | Exercise | Oct 30, 2026 | $0 |